Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z2RM
|
|||
| Former ID |
DNC001727
|
|||
| Drug Name |
ISIS 101997
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MADH6 messenger RNA (MADH6 mRNA) | Target Info | . | [1] |
| KEGG Pathway | Endocytosis | |||
| TGF-beta signaling pathway | ||||
| Panther Pathway | TGF-beta signaling pathway | |||
| Pathway Interaction Database | BMP receptor signaling | |||
| WikiPathways | TGF Beta Signaling Pathway | |||
| Mesodermal Commitment Pathway | ||||
| Signaling by BMP | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Integrated Breast Cancer Pathway | ||||
| Regulation of toll-like receptor signaling pathway | ||||
| BMP Signalling and Regulation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,277,636, Antisense inhibition of MADH6 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.